Cover image not available

Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer

National Institute for Health and Clinical Excellence

Publication Data

Title Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer
Author National Institute for Health and Clinical Excellence
Publisher National Institute for Health and Clinical Excellence
Publication date 2012
Publication location Manchester
Language English

Descriptive Notes

Issued: June 2012.

Topics

Lungs :: Cancer :: Chemotherapy :: England
Lungs :: Cancer :: Chemotherapy :: Wales
Lungs :: Cancer :: Chemotherapy :: England :: Cost effectiveness
Lungs :: Cancer :: Chemotherapy :: Wales :: Cost effectiveness
Protein-tyrosine kinase :: Inhibitors
Epidermal growth factor

Catalogue Data

OBNB ID GBB586188
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.99424061

ISBD

P1053 1 online resource (43 pages).
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2012. Publication and catalogue information, links to buy online and reader comments.